Clinical and molecular features of a Han Chinese family with maternally transmitted hypertension

Jianzhi Shao1, Changgong Chen2, Wenhui Lin1

  • 1Department of Cardiology, Affiliated Wenling Hospital, Wenzhou Medical University China.

Insights

Mitochondrial DNA (mtDNA) mutations are linked to hypertension. This study identified combined mtDNA mutations in a Chinese family, revealing a potential cause for maternally inherited hypertension with high penetrance.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Disease

Background:

  • Mitochondrial DNA (mtDNA) mutations have been implicated in various diseases, including hypertension.
  • Maternally inherited hypertension presents a unique genetic challenge for understanding disease etiology.
  • High penetrance of hypertension within families suggests strong genetic contributions.

Purpose of the Study:

  • To investigate the clinical, genetic, and molecular basis of maternally inherited hypertension in a Han Chinese family.
  • To identify specific mitochondrial DNA mutations associated with high penetrance hypertension.
  • To explore the pathogenic mechanisms of identified mutations in tRNA metabolism and mitochondrial function.

Main Methods:

  • Clinical and pedigree analysis of a Han Chinese family with maternally inherited hypertension.
  • Comprehensive sequencing of the entire mitochondrial genome.
  • Bioinformatic analysis to identify mutations and haplogroup.
  • Localization of mutations within tRNA and protein-coding genes.

Main Results:

  • Identified a high penetrance of hypertension in the studied Han Chinese family.
  • Detected the T4363C mutation in tRNAGln and the ND1 T3394C mutation in the mitochondrial genome.
  • Associated these mutations with human mitochondrial haplogroup M7b.
  • The T4363C mutation is located in a conserved region of the anticodon stem, potentially affecting tRNA metabolism.
  • The ND1 T3394C mutation, previously linked to Leber's hereditary optic neuropathy (LHON), was also found.

Conclusions:

  • The combined mutations ND1 T3394C and tRNAGln T4363C may be pathogenic contributors to hypertension.
  • These mutations could explain the high penetrance and expressivity of hypertension in this family.
  • Further research is warranted to elucidate the precise role of these mtDNA mutations in hypertension pathogenesis.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
385
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
601
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
644
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
304